Journal profile · BIOCHEMISTRY & MOLECULAR BIOLOGY
Transcription-Austin
ISSN 2154-1264 · eISSN 2154-1272 · Taylor & Francis
Transcription-Austin: CAS Zone 3 · Biology (2025 upgraded edition); hybrid open access; median 73 days to acceptance (27 articles, last 24 months); 16 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Transcription-Austin is published by Taylor & Francis and is in Zone 3 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Genomics and Chromatin Dynamics, RNA Research and Splicing and RNA modifications and cancer, together about 45.9% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): BIOCHEMISTRY & MOLECULAR BIOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Genomics and Chromatin DynamicsBiochemistry, Genetics and Molecular Biology19.9%
- RNA Research and SplicingBiochemistry, Genetics and Molecular Biology14.2%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology11.8%
- RNA and protein synthesis mechanismsBiochemistry, Genetics and Molecular Biology11.5%
- Bacterial Genetics and BiotechnologyBiochemistry, Genetics and Molecular Biology4.6%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology3.5%
- DNA Repair MechanismsBiochemistry, Genetics and Molecular Biology3.1%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Biochemistry & Molecular Biology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 6.2LetPub ·
- SJR 2026-06
- 2.68LetPub ·
- SNIP 2026-06
- 0.84LetPub ·
- h-index
- 52OpenAlex ·
- i10-index
- 310OpenAlex ·
- 2-year mean citedness
- 2.85OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 31.43%LetPub ·
Volume
- Articles per year
- 14LetPub ·
Articles by year OpenAlex count · 481 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 12 | 10 | 4 |
| 2025 | 16 | 16 | 48 |
| 2024 | 11 | 11 | 59 |
| 2023 | 14 | 14 | 184 |
| 2022 | 8 | 8 | 186 |
| 2021 | 17 | 17 | 385 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
73 daysMedian, submission to acceptance · P25–P75 53 days – 129 days
- Acceptance to online
- median 18 days (27 articles)
- Submission to online
- median 124 days
- Sample
- 27 articles with submission and acceptance dates (30 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Taylor & Francis
- ISSN
- 2154-1264
- Electronic ISSN
- 2154-1272
FAQ
Frequently asked questions about Transcription-Austin
What CAS zone is Transcription-Austin in?
In the 2025 upgraded edition of the CAS Journal Ranking, Transcription-Austin is in Zone 3 of Biology, and in Zone 3 of the minor category Biochemistry & Molecular Biology. In the 2026 Xinrui edition it is in Zone 2 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Transcription-Austin?
Based on the dates recorded on 27 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 73 days (interquartile range 53–129 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Transcription-Austin?
According to LetPub and DOAJ records, Transcription-Austin is indexed in ESCI and Scopus.
Is Transcription-Austin open access, and what is the APC?
Transcription-Austin is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .